Guideline for the diagnosis and treatment of scabies in Japan (second edition)

Journal of Dermatology

Volumn 35, Issue 6, 2008, Pages 378-393

  Ishii, Norihisa ^a   Asahina, Akihiko ^b   Amagai, Masayuki ^c   Iijima, Masafumi ^d   Ishikawa, Osamu ^e   Imamura, Hidekazu ^f   Ooe, Mariko ^g   Ohtaki, Noriko ^h   Kato, Yasuhiko ⁱ   Kanazawa, Nobuo ^j   Kamide, Ryoichi ^k   Kanzaki, Tamotsu ^l   Konohana, Akira ^l   Komoda, Masayo ^m   Sugiyama, Natsuko ⁿ   Sekine, Mari ^o   Takezaki, Shinichiro ^p   Tanaka, Masaru ^q   Tamura, Nobuko ^r   Nagaoka, Yuzuru ^s   Nanko, Hiroko ^t   Hayashi, Masayuki ^u   Makigami, Kuniko ^u   Matsuda, Tomoko ^v   Yoshizumi, Junko ^w   Wada, Yasuo ^x   more..

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e GUNMA UNIVERSITY   (Japan)

^f Imamura Dermatology Clinic   (Japan)

^g Murahashi Clinic   (Japan)

^h Kudanzaka Hospital   (Japan)

ⁱ Wakayama Medical University ^*

^j WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^k KAGOSHIMA UNIVERSITY   (Japan)

^l SAISEIKAI YOKOHAMASHI NANBU HOSPITAL   (Japan)

^m TOKYO UNIVERSITY OF SCIENCE   (Japan)

ⁿ Kashiwa Municipal Hospital   (Japan)

^o Department of Dentistry Oral surgery   (Japan)

^p NIPPON MEDICAL SCHOOL   (Japan)

^q TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^r YOKOSUKA KYOSAI HOSPITAL   (Japan)

^s National Sanatorium Tama Zenshoen   (Japan)

^t TOKYO KOSEI NENKIN HOSPITAL   (Japan)

^u FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^v Yoshizumi Dermatology Clinic   (Japan)

^w Ako Central Hospital   (Japan)

^x Department of Neurosurgery   (Japan)

more..

Author keywords

Crotamiton; Crusted scabies; Dermoscopy; Guideline; Ivermectin; Scabies

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIHISTAMINIC AGENT; ASPARTATE AMINOTRANSFERASE; BENZYL BENZOATE; BILIRUBIN; CROTAMITON; CYTOCHROME P450 3A4; DRUG VEHICLE; EMULSIFYING AGENT; HEXACHLOROCYCLOHEXANE; IVERMECTIN; ORGANOSULFUR DERIVATIVE; PERMETHRIN; PHENOTHRIN; SULFUR DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; APLASTIC ANEMIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BATH; BED; BILIRUBIN BLOOD LEVEL; BLOOD BRAIN BARRIER; BREAST FEEDING; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT DERMATITIS; DERMATITIS; DRUG ABSORPTION; DRUG DEGRADATION; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG INDICATION; DRUG INTERMITTENT THERAPY; DRUG METABOLISM; DRUG SAFETY; DRUG STABILITY; DRUG TRANSPORT; ECOLOGY; EGG; EPIDEMIC; EPILUMINESCENCE MICROSCOPY; FILARIASIS; FINGER; GENITAL SYSTEM; GROUPS BY AGE; HAND; HAND WASHING; HEALTH CARE FACILITY; HEALTH INSURANCE; HEMATOLOGY; HEMATURIA; HOT FLUSH; HUMAN; HYDROPHILICITY; INFECTION CONTROL; INFECTION PREVENTION; JAPAN; LEUKOCYTE COUNT; LOTION; LYMPHOCYTE COUNT; MEDICAL SOCIETY; MICROSCOPY; MITE; MULTIPLE CYCLE TREATMENT; NONHUMAN; ONCHOCERCIASIS; OPTIMAL DRUG DOSE; OUTPATIENT CARE; PARASITE TRANSMISSION; PATIENT CARE; PRACTICE GUIDELINE; PREGNANCY; PROTECTIVE CLOTHING; PRURITUS; REPEATED DRUG DOSE; REVIEW; RISK BENEFIT ANALYSIS; SARCOPTES SCABIEI; SCABIES; SIDE EFFECT; SINGLE DRUG DOSE; SKIN IRRITATION; SYMPTOMATOLOGY; TERATOGENICITY; TOXIC EPIDERMAL NECROLYSIS; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WARD;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANIMALS; ANTIPARASITIC AGENTS; FEMALE; HUMANS; INFECTION CONTROL; INSECTICIDES; IVERMECTIN; PREGNANCY; SARCOPTES SCABIEI; SCABIES; SKIN;

EID: 45249093021     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2008.00491.x     Document Type: Review

References (82)

1. Executive committee of guideline for the diagnosis treatment of scabies. [Guideline for the diagnosis and treatment of scabies.] Jpn J Dermatol 2005 115 : 1125 1129. [In Japanese.]
2. Burgess I. Advances in Parasitology 33. In : Baker JR, Muller R (eds). Sarcoptes scabiei and scabies. Academic Press, London 1994 235 292.
3. Hayashi, M. Scabies. In : Nagatani T, Miyabayashi T, Yamamoto I, Hayashi M (eds). [The skin diseases in the bedridden old.] Medicalsense Co, Tokyo 2000 68 89. [In Japanese.]
4. Ohtaki N, Makigami K, Seki N. [Scabies-no Spooky.] Igakushoin, Tokyo 2002 1 137. [In Japanese.]
5. Chosidow O. Scabies. N Engl J Med 2006 354 : 1718 1727.
6. Uchikawa K. [Biology of Sarcoptes scabiei.] Infect Agents Surveillance Report 2001 22 : 246 247. [In Japanese.]
7. Heilesen B. Studies on Acarus scabiei and scabies. Acta Dermato-Venereologica 1946 26 (Suppl. 14 151 153.
8. Hayashi M. [The skin diseases and life conduct.] Practical Dermatol 1998 20 : 469 475. [In Japanese.]
9. Walton SF, Holt DC, Currie BJ, Kemp DJ. Scabies: new future for a neglected disease. Adv Parasitol 2004 57 : 309 376.
10. Arlian LG, Runyan RA, Achar S, Estes SA. Survival and infectivity of Sarcoptes scabiei var. canis and var. homines. J Am Acad Dermatol 1984 11 : 210 215.
11. Maie O. [Scabies infected from others hands and arms Visual Dermatol 2003 2 : 778 779. [In Japanese.]
12. Johnson CG, Mellanby K. The parasitology of human scabies. Parasitol 1972 34 : 285 290.
13. Mellanby K. Biology of the parasite. In : Orkin M, Maibach HI, Parish LC, Schwartzman RM (ed.) Scabies and Pediculosis. J.B. Lippincott Co., Philadelphia 1977 8 16.
14. Wada Y. [A method for the detection of the scabies mite based on the biology of Sarcoptes scabiei.] Jpn J Clin Dermatol 2005 59 (Suppl 66 70. [In Japanese.]
15. von Hebra F. Scabies. In : Pye-Smith PH (ed.) On Diseases of the Skin Including Exanthemata. Vol II, The New Sydenham Society, London 1868 207.
16. Kaposi M. Scabies. In : Johnston JC (ed.) Diseases of the Skin. Tindall and Cox, London 1895, 655.
17. Yoshizumi J. [Scabies love creases - follow the "wake" left by the mite.] Practical Dermatol 2006 28 : 343 350. [In Japanese.]
18. Wada Y. [Was there a name of "wake sign" in the past?] Practical Dermatol 2006 28 : 1517. [In Japanese.]
19. Yoshizumi J. [Has the scabies burrow being described as leaving a "wake"?] Practical Dermatol 2006 28 : 1518. [In Japanese.]
20. Yoshizumi J, Tanaka M. [Dermoscopy: a useful technique for making diagnosis of scabies.] Visual Dermatol 2007 6 : 262 263. [In Japanese.]
21. Nanko H. [Skin diseases characterized in elderly person.] Rinsho Derma 2001 43 (Suppl 1371 1377. [In Japanese.]
22. Katsumata K, Katsumata K. Simple method of detecting Sarcoptes scabiei var. hominis mites among bedridden elderly patients suffering from severe scabies infestation using an adhesive-tape. Intern Med 2006 45 : 857 859.
23. Uenotsuchi T, Moroi Y, Urabe K, Tsuji G, Takahara M, Furue M. The scybala(fecal pellets) of Sarcoptes scabiei var. hominis are obviously stained with chlorazol black E. J Dermatol 2004 31 : 511 512.
24. Wada Y. [Diagnostic methods for the detection of Sarcoptes scabiei based on its biology.] Monthly Book Derma 2005 101 : 51 56. [In Japanese.]
25. Kusunoki T. [Capture method of scabies mite.] Visual Dermatol 2005 4 : 1214 1215. [In Japanese.]
26. Juranek DD. Scabies control in institutions. In : Orkin M, Maibach HI (eds). Cutaneous infestations and insect bite. Marcel Dekker, New York 1985 139 156.
27. Ishii N, Miyazawa M, Kawaguchi H, Inami S, Nakajima H. [Statistical analysis of scabies.] STD 1989 70 : 19 21. [In Japanese.]
28. Lettau LA. Nosocomial transmission and infection control aspects of parasitic and ectoparasitic diseases. Part III. Ectoparasites/summary and conclusions. Infect Control Hosp Epidemiol 1991 12 : 179 185.
29. Yamada N, Iida R, Nakazawa K, Tsukamoto K, Shimada S. [Macroscopic feature of scabies burrow.] Rinsho Derma 1997 39 : 681 682. [In Japanese.]
30. Nagakura K, Fukaya Y, Kitaharashou Y. [Situation of scabies infestation at elderly facilities in Kanagawa Prefecture.] Jpn J Environ Infect 2001 16 : 216 219. [In Japanese.]
31. Makigami K, Ohtaki N, Sato Y, Yamaguchi N. [Nosocomial outbreak of scabies in a psychiatric hospital - epidemiological assessment and prophylactic treatment with oral ivermectin.] Jpn J Hyg 2005 60 : 450 460. [In Japanese.]
32. Ohtaki N. [Scabies - diagnosis, treatment, and prevention.] Antibiot Chemother 2003 19 : 70 74. [In Japanese.]
33. Otaki N. Scabies Rinsho Derma 2003 45 : 1495 1501. [In Japanese.]
34. Taplin D, Meinking TL, Chen JA, Sanchez R. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990 7 : 67 73.
35. National Institute of Health Science (NIHS). [International Chemical Safety Cards (ICSC).] 2005. [In Japanese.]
36. Matsuoka T, Furuno T, Komoda M. [Problem in use of γ-BHC (lindane) for treatment of scabies - transdermal absorption and stability of γ-BHC ointment.] Jpn J Pharmaceut Health Care Sci (in press). [In Japanese.]
37. Bhalla M, Thami GP. Reversible neurotoxicity after an overdose of topical lindane in an infant. Pediatr Dermatol 2004 21 : 597 599.
38. Ratra GS, Kamita SG, Casida JE. Role of human GABAa receptor beta3 subunit in insecticide toxicity. Toxicol Appl Pharmacol 2001 172 : 233 240.
39. Schultz MW, Gomez M, Hansen RC et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol 1990 126 : 167 170.
40. Bigby M. A systematic review of the treatment of scabies. Arch Dermatol 2000 136 : 387 389.
41. Walker GJA, Johnstone PW. Intervention for treating scabies. Cochrane Database Syst Rev 2000 3 : CD000320.
42. Kobayashi A. [Evermectin and its derivative ivermectin - problem of name of ivermectin.] Practical Dermatol 2002 24 : 541 542. [In Japanese.]
43. Ishii N. [Treatment of scabies and ivermectin.] Nikkei Med 2005 454 : 123 125. [In Japanese.]
44. Brownlee DJ, Holden-Dye L, Walker RJ. Actions of the anthelmintic ivermectin on the pharyngeal muscle of the parasitic nematode, Ascaris suum. Parasitol 1997 115 : 553 561.
45. Dawson GR, Wafford KA, Smith A et al. Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the γ-aminobutyric acid(A) receptor. J Pharmacol Exp Ther 2000 295 : 1051 1060.
46. Ikeda T. [Pharmacological effects of ivermectin, an antiparasitic agent for intestinal strongyloidiasis: its mode of action and clinical efficacy.] Folia Pharmacol Jpn 2003 122 : 527 538. [In Japanese.]
47. Ohtomo K, Togaki M, Komatsuzaki M, Kanemitsu K, Kunishima K. [Study on safety and effectiveness of ivermectin against scabies.] Report from the MHW Group for Research and Dev of Drugs for Treatment of Tropical Dis 2004 1 5. [In Japanese.]
48. Lankas GR, Minsker DH, Robertson RT. Effects of ivermectin on reproduction and neonatal toxicity in rats. Food Chem Toxicol 1989 27 : 523 529.
49. Fisher MH, Mozik H. The chemistry and pharmacology of avermectins. Ann Rev Pharmacol Toxicol 1992 32 : 537 553.
50. Lankas GR, Cartwright ME, Umbenhauer D. P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity. Toxicol Appl Pharmacol 1997 143 : 357 365.
51. Kwei GY, Alvaro RF, Chen Q et al. Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein. Drug Metab Dispos 1999 27 : 581 587.
52. McEvoy GK, Miller J, Litvak K. AHFS Drug Information 2004. American Society of Health-System Pharmacists, Bethesda 2004.
53. Ishii N, Komoda M. [Effect of ivermectin on scabies.] Jpn J Clin Dermatol 2003 57 (Suppl 135 138. [In Japanese.]
54. Goto N, Suda N, Shiraishi T et al. [A drug utilization study on pharmaceutical preparations for scabies: the prevalence of scabies and its management.] Jpn J Pharmaceut Health Care Sci 2003 29 : 665 670. [In Japanese.]
55. Haas N, Lindemann U, Frank K, Sterry W, Lademann J, Katzung W. Rapid and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies. Arch Dermatol 2002 138 : 1618 1619.
56. Pacque M, Munoz B, Greene BM, White AT, Dukuly Z, Taylor HR. Safety of and compliance with community-based ivermectin therapy. Lancet 1990 335 : 1377 1380.
57. Meinking TL, Taplin D, Hermida JL, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. N Engl J Med 1995 333 : 26 30.
58. Dourmishev A, Serafimova D, Dourmishev L. Efficacy and tolerance of oral ivermectin in scabies. J Eur Acad Dermatol Venereol 1998 11 : 247 251.
59. del Giudice P, Marty P, Gari-Toussaint M, Le Fichoux Y. Ivermectin in elderly patients. Arch Dermatol 1999 135 : 351 352.
60. del Giudice P, Marty P. Ivermectin: a new therapeutic weapon in dermatology? Arch Dermatol 1999 135 : 705 706.
61. Elmogy M, Fayed H, Marzok H, Rashad A. Oral ivermectin in the treatment of scabies. Int J Dermatol 1999 38 : 926 930.
62. Conti Diaz IA, Amaro J. Treatment of human scabies with oral ivermectin. Rev Inst Med Trop S Paulo 1999 41 : 259 261.
63. De Sole G, Remme J, Awadzi K et al. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull World Health Organ 1989 67 : 707 719.
64. Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kmagno J, Chippaux JP, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for loa loa infection. Lancet 1997 350 : 18 22.
65. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 1997 349 : 1144 1145.
66. Bredal WP. Deaths associated with ivermectin for scabies. Lancet 1997 350 : 216.
67. Kodama M, Kobayashi S, Tanikawa A et al. [Efficacy of ivermectin against scabies - A case report and summary of 25 cases in our department.] Jpn J Clin Dermatol 2001 55 : 273 276. [In Japanese.]
68. Ohtaki N. [Ivermectin in the treatment of scabies.] Jpn J Clin Dermatol 2002 56 (Suppl 165 167. [In Japanese.]
69. Ohtaki N, Taniguchi H, Ohtomo H. Oral ivermectin treatment in two cases of scabies: effective in crusted scabies induced by corticosteroid but ineffective in nail scabies. J Dermatol 2003 30 : 411 416.
70. Ohtaki N. [Various features of scabies.] Practical Dermatol 2003 55 (Suppl 124 129. [In Japanese.]
71. Shudo Y, Mitsui J, Hamada A, Kimura M. [The effect of ivermectin in 22 scabies patients.] Clin Parasitol 2004 14 : 104 106. [In Japanese.]
72. Hitani A, Kimura M. [Efficacy of ivermectin in the treatment of endemic of scabies in a hospital.] Clin Parasitol 2004 15 : 68 71. [In Japanese.]
73. Higaki Y, Tamai E. [Effectiveness and safety of ivermectin for scabies in 18 bedridden elder-care facility patients.] Shimane Igaku 2004 24 : 52 57. [In Japanese.]
74. Ohtaki N, Taniguchi H, Makigami K. [Efficacy of ivermectin in the treatment of endemic of scabies in a nursing home.] Jpn J Clin Dermatol 2005 59 : 692 698. [In Japanese.]
75. Tamura N, Ishii N. [Efficacy of ivermectin treatment in elderly scabies patients.] Jpn J Dermatol 2005 115 : 2405 2407. [In Japanese.]
76. Nakamura R, Taniguchi H, Ohtaki N. A case of crusted scabies with a bullous pemphigoid-like eruption and nail involvement. J Dermatol 2006 33 : 196 201.
77. Zeng Z, Andrew NW, Arison BH, Luffer-Atlas D, Wang RW. Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes. Xenobiotica 1998 28 : 313 321.
78. Currie BJ, Harumal P, McKinnon M, Walton SF. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004 39 : 8 12.
79. Nishi K, Tsuji H, Nakamura T, Yamamoto A, Iizuka H. [Post-scabetic nodules.] Practical Dermatol 2005 27 (Suppl 39 42. [In Japanese.]
80. Obara A. [Prevention of scabies-recent insectcides supplied from over the counter.] Visual Dermatol 2003 2 : 812 814. [In Japanese.]
81. Bannatyne RM, Patterson TA, Wells BA, MacMillan SA, Cunningham GA, Tellier R. Hospital outbreak traced to a case of Norwegian scabies. Can J Infect Control 1992 7 : 111 113.
82. Ohtaki N. [The prevalence of scabies.] Med Entomol Zool 1998 49 : 15 26. [In Japanese.]